Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Government Accountability Office. Drug Safety: Preliminary Findings Suggest Weaknesses in FDA's Program for Inspecting Foreign Drug Manufacturers. GAO-08-224T. Washington, DC, 2007. https://www.govinfo.gov/app/details/GAOREPORTS-GAO-08-224T
Government Accountability Office. (2007, November 1). GAO-08-224T - Drug Safety: Preliminary Findings Suggest Weaknesses in FDA's Program for Inspecting Foreign Drug Manufacturers. [Government]. U.S. Government Printing Office. https://www.govinfo.gov/app/details/GAOREPORTS-GAO-08-224T
Government Accountability Office. GAO-08-224T - Drug Safety: Preliminary Findings Suggest Weaknesses in FDA's Program for Inspecting Foreign Drug Manufacturers. U.S. Government Printing Office, (1 Nov 2007), https://www.govinfo.gov/app/details/GAOREPORTS-GAO-08-224T
Government Accountability Office, Drug Safety: Preliminary Findings Suggest Weaknesses in FDA's Program for Inspecting Foreign Drug Manufacturers, GovInfo, (November 1, 2007), https://www.govinfo.gov/app/details/GAOREPORTS-GAO-08-224T